skip to primary navigationskip to content

Dr Nozomi Itani

Dr Nozomi Itani

Research Associate

Research Interests

I’m interested in fetal origins of cardiovascular disease in adverse pregnancy.

Chronic fetal hypoxia and associated fetal growth restriction is one of the most common consequences of complicated pregnancy, such as during placental insufficiency and preeclampsia.  Chronic fetal hypoxia increases oxidative stress in the fetal heart and circulation and programmes cardiovascular disease in the adult offspring.  Given the global epidemic in heart and vascular disease, there is an urgent need to identify preventative therapy, particularly following clinical diagnosis of fetal growth restriction. My research investigates the effect of antioxidant therapies on the fetal cardiovascular system during hypoxic development. 


(DOHaD) ; antioxidant ; Developmental Origins of Health Disease ; preventative therapy

Key Publications

Itani, N., Skeffington, K.L., Beck, C., Giussani, D.A. (2016). Sildenafil therapy for fetal cardiovascular dysfunction during hypoxic development: Studies in the chick embryo. Journal of Physiology doi: 10.1113/JP273393

Itani, N., Skeffington, K.L., Beck, C., Niu, Y., Giussani, D.A. (2016). Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo. Journal of Pineal Research 60(1), 16-26.

Giussani, D.A., Niu, Y., Herrera, E.A., Richter, H.G., Camm, E.J., Thakor, A.S., Kane, A.D., Hansell, J.A., Brain, K.L., Skeffington, K.L., Itani, N., Wooding, F.B., Cross, C.M., Allison, B.J. (2014). Heart Disease Link to Fetal Hypoxia and Oxidative Stress. Advances in Experimental Medicine and Biology 814, 77-87.


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan